About theblood
theblood is a Healthcare company based in Berlin (Germany) founded in 2022 by Isabelle Guenou, Miriam Santer, and Lucas Mittelmeier. Menstrual blood testing kits are manufactured for health diagnostics. It operates on a HealthTech model. theblood has raised $1.07 million across 1 funding round from investors including RoX Health and Leanox. Its chief executive, as recorded, is Isabelle Guenou. theblood offers products and services including Menstrual Blood Test. Its focus areas include Medical Diagnostics and Women's Health. Its legal entity is theblood GmbH.
Company details
Menstrual blood testing is offered by theblood to provide insights into womens health. Focus is placed on fertility, early menopause, hormonal imbalances, pain, and skin issues like acne. A non-invasive alternative to traditional blood tests is delivered, enabling regular tracking of health biomarkers. Solutions are developed to address the gender data gap in healthcare, ensuring timely diagnoses and informed health decisions for women.
- Headquarters Berlin, Germany
- Founders Isabelle Guenou, Miriam Santer, Lucas Mittelmeier
- SectorsHealthcare
- Email••••••••
- Website theblood.io
- Social LinkedIn Facebook Instagram
- Legal Name Theblood Gmbh
- Total Equity Funding$1.07M (USD)
in 1 rounds
- Latest Funding Round$1.07M (USD), Seed
Mar 2023
- InvestorsRoX Health
& 1 more
Products & Services of theblood
theblood offers a comprehensive portfolio of products and services, including Menstrual Blood Test.
Menstrual blood is analyzed for health insights.
Funding Insights of theblood
theblood has successfully raised a total of $1.07M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.07 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.07M
- Total Rounds 1
- Last Round Seed — $1.07M
- First Round $1.07M
(Mar 2023)
- Investors Count 2
All 1 funding rounds of theblood with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2023 | $1.07M | Seed | – | – |
2 investors in total: 2 institutional.
Investors in theblood
theblood has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include RoX Health and Leanox.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| leanox.eu | ||||
Empowers early-stage digital health startups through expertise, networks, and industry insights. | 2020 | roxhealth.com | Berlin, Germany |
Investor details for theblood
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of theblood
3 people are tracked at theblood (3 in leadership).
| Name | Role | Group |
|---|---|---|
Isabelle Guenou | Co-Founder & CEO | Leadership |
Miriam Santer | Co-Founder | Leadership |
Lucas Mittelmeier | Co-Founder | Leadership |
Complete people profiles for theblood
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of theblood
2 dated milestones of theblood across 1 years, from founding to its latest funding, stage changes and deals.
- Founded theblood is founded.
- Funding First funding round of $1.1M.
Web traffic of theblood
The website of theblood (theblood.io) receives about 5.8K visits a month.
- Monthly visits5.8K
▲ 12.3% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about theblood
theblood was founded in 2022 and raised its 1st funding round 1 year after it was founded.
theblood is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Isabelle Guenou is the CEO of theblood, as recorded in our data. They have also founded this company.
theblood is a funded company, having raised a total of $1.07M across 1 funding round to date. The company's 1st funding round was a Seed of $1.07M, raised on Mar 2023.
Menstrual blood testing is offered by theblood to provide insights into womens health. Focus is placed on fertility, early menopause, hormonal imbalances, pain, and skin issues like acne. A non-invasive alternative to traditional blood tests is delivered, enabling regular tracking of health biomarkers. Solutions are developed to address the gender data gap in healthcare, ensuring timely diagnoses and informed health decisions for women.
theblood offers Menstrual Blood Test.
theblood has 2 investors. Key investors include RoX Health, and Leanox.
theblood operates through Theblood Gmbh.